Topics

UniQure gene therapy shows rise in blood-clotting protein in trial

07:29 EST 8 Feb 2019 | Reuters

UniQure NV said on Friday its gene therapy to treat patients with a blood disorder, hemophilia B, increased the levels of a protein that helps in blood clotting after 12 weeks.

Original Article: UniQure gene therapy shows rise in blood-clotting protein in trial

NEXT ARTICLE

More From BioPortfolio on "UniQure gene therapy shows rise in blood-clotting protein in trial"

Quick Search

Relevant Topic

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...